Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Advancements in endoscopic closure techniques for gastrointestinal luminal defects comparative perspectives on OTSC, endo suturing, TTS clips, and X-Tack
Prasanth, Mahesh, Saeed, Noora , Shehzadi, Tusneem, Hasan, Zim Warda, Khan, Nazir, Tanush, Dev, Aminpoor, Hasibullah , Mohan, Anmol, Aminpoor, Hasibullah , Mohan, Anmol , Saeed, Namra Asif, Shehzadi, Tusneem, Hasan, Zim Warda, Khan, Nasar Nasrullah

Annals of Medicine & Surgery | August 6, 2025 | Volume: 87 | Issue: 8 | Pages: 5077-5086

10.1097/ms9.0000000000003571 | PMID 40787569 Get It

Gastrointestinal (GI) defects pose a significant clinical challenge, impacting patient outcomes and healthcare costs. Endoscopic closure techniques have emerged as effective and minimally invasive approaches to manage these defects. This review explores the various endoscopic techniques, including over-the-scope clips (OTSC), endo suturing systems, through-the-scope (TTS) clips, and the X-Tack system. Each technique offers distinct advantages and limitations, making it suitable for specific clinical scenarios. While these devices have demonstrated promising results in clinical practice, further research is needed to optimize their use and address knowledge gaps. Large-scale randomized controlled trials are essential to establish evidence-based guidelines for device selection and procedural techniques. By embracing technological advancements and addressing research limitations, the field of endoscopic closure devices has the potential to revolutionize GI care, leading to improved patient outcomes and expanded therapeutic possibilities.
The Use of Perioperative Cephalexin in Penicillin Allergic Patients in Dermatologic Surgery: An Advisory Statement
Campbell, Elliott H. , Virk, Abinash , Otley, Clark C. , Lessard, Sarah , Otley, Clark, Gonzalez‐Estrada, Alexei

Dermatologic Surgery | August 6, 2025 | Volume: 52 | Issue: 3 | Pages: 221-225

10.1097/dss.0000000000004784 | PMID 40767862 Get It

BACKGROUND Approximately 10% of patients report penicillin allergy. Based on historical guidelines, patients with a penicillin allergy should receive an alternative to cephalexin for prophylaxis in dermatologic surgery. OBJECTIVE To determine, based on evidence, if cephalexin should be used as a first-line prophylactic antibiotic in dermatologic surgery for patients with penicillin allergy. METHODS Systematic review of the literature was performed with defined search terms. RESULTS Less than 5% of those with penicillin allergy labels have a true penicillin allergy. For patients with true, persistent penicillin allergy, there is an overall low cross-reactivity with cephalosporins, especially with cephalosporins that do not share identical R1 side chain. The first-generation cephalosporins, including cephalexin, have a slightly higher risk of cross-reactivity in patients with reported allergy to amino-penicillins (amoxicillin, ampicillin) but not other penicillins. The risk of severe cross-reactivity of cephalosporins in patients with low-risk penicillin allergies is extremely low. Cephalexin has a superior side effect profile and efficacy compared to alternatives. CONCLUSION Cephalexin should be used as the first-line prophylactic antibiotic in dermatologic surgery for patients with documented penicillin allergy, including anaphylaxis. There may be a higher risk of cross-reactivity with cephalexin in patients with a confirmed amino-penicillin allergy.
Global Variations in Practices After Bariatric and Metabolic Surgery; the PARTNER study
Clyde, Danielle , Grant, Callum, Canales, Juan Andres Aguiar, Adib, Reza, Baig, Sarfaraz Jalil , Bhasker, Aparna Govil , Beaux, Andrew de, Drummond, Gillian, Fawal, Hayssam, Goodpaster, Kasey , Hopkins, George, Jatana, Anita , Kothari, Shanu N. , Kow, Lillian, Faria, Sílvia Leite , Madhok, Brij, Mahon, David, Miller, Karl , Nimeri, Abdelrahman , O’Kane, Mary , Poggi, Luis , Ratcliffe, Denise , Sarkar, Rupa , Shenfine, Jon, Sogg, Stephanie , Suter, Michel , Taha, Safwan , Voon, Kelvin , Lamb, Peter , Mahawar, Kamal , Grant, Callum, Canales, Juan Andres Aguiar, Cameron, David, Copăescu, Cătălin , Clare, Ken , Fried, Martin , Graham, Yitka N. H. , Goel, Ramen , Hazebroek, Eric J. , Husain, Farah Anwari , Joyce, Brian, Kermansaravi, Mohammad , Miras, Alexander Dimitri , Moizé, Violeta , Neto, Manoel Galvão , Peterli, Ralph , Sakran, Nasser , Salminen, Paulina , Singhal, Rishi , Stenberg, Erik , Tahrani, Abd A. , Vilallonga, Ramón , Welbourn, Richard , Zerrweck, Carlos , Moussa, Osama , Byrne, James Patrick , Parmar, Chetan D. , Ghanem, Omar M. , Robertson, Andrew G. , Yang, Wah

No container title available | August 6, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6779565/v1 Get It

Abstract Background: With over 1 billion individuals affected globally, obesity and obesity related diseases is now a leading cause of death. Metabolic and bariatric surgery (MBS) has emerged as a cornerstone intervention for severe obesity and its associated comorbidities. Despite its efficacy, postoperative care and follow-up after MBS remains highly variable worldwide. Objective: The PARTNER study aimed to evaluate global clinical practices in the postoperative management following MBS by surveying multidisciplinary healthcare professionals . Methods: This study was an international online survey conducted between October 2024 and January 2025. A multidisciplinary team developed the questionnaire based on existing literature and international guidelines. The survey assessed five domains: follow-up care, postoperative treatment, dietary management, patient support, and measurement of surgical outcomes. Responses were analysed descriptively. Results: A total of 262 responses were received from 62 countries. Most respondents were bariatric surgeons (72.1%) working in public healthcare systems (73.3%). While 78.7% reported conducting three-month postoperative reviews, only 23.7% offered indefinite follow-up. Hybrid models of care (virtual and in-person) were common (56.9%). VTE prophylaxis and postoperative PPI use were recommended by 64.1% and 84.3% respectively. Nearly all respondents (98.1%) provided dietary advice, with protein and micronutrient supplementation widely endorsed. Only 56.1% routinely referred patients for psychological follow-up. Definitions of surgical success and failure varied widely, with inconsistent objective outcome measures. Conclusion: The PARTNER study reveals significant international variation in postoperative management practices following MBS. These findings underscore the need for more standardized, evidence-based guidelines to improve long-term outcomes and equity of care worldwide.
Hyperoxia and End-Organ Complications Among Cardiogenic Shock Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation
Wang, Jeffrey , Gangavelli, Apoorva , Tonna, Joseph E. , Magruder, J. Trent , Yalamuri, Suraj , Miller, P. Elliott , Tonna, Joseph E. , Wang, Jeffrey , Zaaqoq, Akram , Jentzer, Jacob C.

Critical Care Medicine | August 6, 2025 | Volume: 53 | Issue: 10 | Pages: e2043-e2053

10.1097/ccm.0000000000006810 | PMID 40767559 Get It

OBJECTIVES: To investigate whether severe hyperoxia predisposes to end-organ complications and whether these complications contribute to in-hospital mortality among cardiogenic shock (CS) patients supported in venoarterial extracorporeal membrane oxygenation (VA-ECMO). DESIGN: Adult patients with CS from the Extracorporeal Life Support Organization Registry between 2010 and 2023 were categorized into normoxia (Pao 2 60–150 mm Hg), mild hyperoxia (Pao 2 151–300 mm Hg), and severe hyperoxia (Pao 2 > 300 mm Hg) based on their Pao 2 at 24 hours. The primary outcome was in-hospital mortality. End-organ complications were analyzed using multivariate logistic regression models, and causal mediation analysis was performed to estimate the direct and indirect effects of hyperoxia on mortality. SETTING: Multicenter, multinational prospective cohort study. PATIENTS: Adults with CS supported on VA-ECMO. INTERVENTIONS: Partial pressure of oxygen at 24 hours after VA-ECMO cannulation. MEASUREMENTS/MAIN RESULTS: A total of 10,541 patients were included (normoxia: 48.4%, mild hyperoxia: 30.0%, severe hyperoxia: 21.5%). There was higher in-hospital mortality in patients with severe hyperoxia (71.7%, adjusted OR [aOR]: 2.17; 95% CI, 1.19–2.50) and mild hyperoxia (63.8%, aOR: 1.34; 95% CI, 1.19–1.50) compared normoxia (52.7%; referent group). Severe hyperoxia was associated with more end-organ complications, which incrementally predicted higher mortality (aOR: 1.42; 95% CI, 1.25–1.61). Mediation analysis demonstrated that hyperoxia primary exerted a direct effect on mortality (86%), with contributions from neurologic (3.1%), hepatic (3.9%), renal (3.5%), and bleeding (2.3%) complications. CONCLUSIONS: Severe hyperoxia in patients with CS receiving VA-ECMO is associated with increased mortality and more end-organ complications. However, most of the effect of severe hyperoxia on mortality occurs via direct effects, independent of end-organ complications. These findings highlight the potential direct toxicity of hyperoxia and underscore the need for strategies to optimize oxygen delivery in this critically ill population.
Navigating Maternity Leave and Return-to-Work During Radiology Residency: Lessons Learned and Practical Tips
Yancey, Kristina

American Journal of Roentgenology | August 6, 2025 | Volume: 225 | Issue: 5 | Pages: No page available

10.2214/ajr.25.33444 | PMID 40767630 Get It

Sections Don't Lie: AI-driven Breast Cancer Detection Using MRI
Moassefi, Mana , Li, Xiao , Xiao, Lekui, Moassefi, Mana

Radiology: Artificial Intelligence | August 6, 2025 | Volume: 7 | Issue: 5 | Pages: No page available

10.1148/ryai.250520 | PMID 40767605 Get It

Factors Influencing the Duration From the Initiation of Surgical Evaluation to Final Intervention in Pediatric Epilepsy Surgery
Al‐Ramadhani, Ruba , Hyslop, Ann , Caraway, Avery Robert, Ostendorf, Adam P. , Alexander, Allyson , Depositario‐Cabacar, Dewi F., Karia, Samir , Tatachar, Priyamvada, Bolton, Jeffrey , Pichon, P, Shrey, Daniel W. , Romanowski, Erin Fedak , Auguste, Kurtis I. , Bernardo, Danilo , Singh, Rani K., Reddy, Shilpa B. , Ganesh, Abhinaya, Ciliberto, Michael A. , Samanta, Debopam , Arredondo, Kristen H. , Marashly, Ahmad , Wagner, Janelle L. , Miller, D. , Galán, Fernando , Perry, Μ. Scott , Caraway, Avery R. , Wong-Kisiel, Lily C. , Gonzalez-Giraldo, Ernesto , Samanta, Debopam , Galan, Fernando N , Hyslop, Ann , Miller, Derryl J , Caraway, Avery Robert , Novotny, Edward J. , Eschbach, Krista , Wong‐Kisiel, Lily C. , Depositario‐Cabacar, Dewi, Oluigbo, Chima , Karakas, Cemal , Tatachar, Priyamvada , McNamara, Nancy , Gonzalez‐Giraldo, Ernesto , Javarayee, Pradeep , Lin, Jenny J. , Coryell, Jason , Ganesh, Abhinaya, Grinspan, Zachary M. , Armstrong, Dallas , Abel, Taylor J.

Annals of the Child Neurology Society | August 6, 2025 | Volume: 3 | Issue: 3 | Pages: 188-200

10.1002/cns3.70027 | PMID 42563855 Get It

ABSTRACT Rationale Longer duration of epilepsy before surgery is a predictor of poor outcome. While referral delays of surgical candidates are well documented, factors causing delay during the presurgical evaluation remain unclear and may vary depending on institutional characteristics. By benchmarking the duration of presurgical evaluation across multiple centers and identifying patient and evaluation characteristics contributing to duration, we can ascertain best practices and address modifiable contributors to reduce delays. Methods We queried the Pediatric Epilepsy Research Consortium Surgery Database, a prospective, observational multicenter study enrolling children 0–18 years at 27 US pediatric epilepsy centers, for all patients undergoing initial presurgical evaluation for drug‐resistant epilepsy (DRE). We included patients with completed evaluations and data on duration from initiation of presurgical evaluation to final surgical decision. We compared patient characteristics and evaluation components between those with long duration evaluations (> 75% quartile) and those with short evaluations (< 25% quartile). Akaike information criteria selection identified variables associated with longer duration. From these, we developed a logistic prediction model for evaluation duration, using a random 80/20 training/testing split of the entire cohort. The model was tested among institutions with ≥ 10 patients in the cohort to assess its accuracy in predicting long durations. Linear models for each site assessed each variable's impact on duration. Variables with < 10% of the patient population at each site were excluded. Beta values were compared to identify intra‐ and inter‐institution variability and to delineate institutions with the shortest added duration for each variable. Results Of 2318 patients undergoing surgical evaluation, 1655 (71%) from 23 sites had complete data. Median evaluation duration was 8 weeks (interquartile range 3–22); 453 (27%) were short‐duration evaluations and 414 (25%) were long‐duration evaluations. Multiple patient and evaluation characteristics were associated with duration (Table 1). Table 6 provides the average duration each variable contributes to evaluation by site, highlighting the shortest durations compared with other groups. Conclusions Duration of presurgical evaluation for DRE can be accurately modeled using multiple patient characteristics and testing strategies commonly employed in epilepsy surgery evaluations. This predictive model can not only estimate evaluation duration but also identify opportunities to improve systemic efficiency. Institution‐level modeling identifies specific program strengths, providing an opportunity to learn from successful processes. Subsequent research will focus on institutional process mapping to better understand systemic practices that lead to improved efficiencies, then sharing these processes across the consortium to shorten evaluation durations.
Long‐Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry
Higgins, Angela Y. , Zimmerman, Sarah , Wang, Yongfei , Faridi, Kamil F. , Price, Matthew J. , Holmes, David R. , Curtis, Jeptha P. , Freeman, James V. , Friedman, Daniel J , Faridi, Kamil F , Price, Matthew J , Reddy, Vivek Y , Holmes, David R , Curtis, Jeptha P , Freeman, James V , Higgins, Angela Y. , Reddy, Vivek Y.

Journal of the American Heart Association | August 6, 2025 | Volume: 14 | Issue: 16 | Pages: No page available

10.1161/jaha.124.039780 | PMID 40767285 Get It

Background Percutaneous left atrial appendage occlusion (LAAO) is an alternative to long‐term anticoagulation for preventing ischemic stroke in patients with atrial fibrillation. There are limited long‐term outcomes data for “real‐world” patients undergoing LAAO. Methods We performed a retrospective cohort study using the National Cardiovascular Data Registry LAAO registry from January 1, 2016, through December 31, 2019. We linked LAAO data to inpatient Medicare fee‐for‐service claims data using probabilistic matching to establish a cohort of patients 65 years and older undergoing LAAO with a WATCHMAN device. The primary outcomes were any stroke and all‐cause mortality. Results A total of 34 975 patients with a mean±SD CHA 2 DS 2 ‐VASc (congestive heart failure, hypertension, age ≥75 years, diabetes, previous stroke or transient ischemic attack, vascular disease, age 65 to 74 years, and sex category) score of 4.7±1.4 were included. The median follow‐up was 2.8 years (interquartile range, 2.2–3.7 years). The cumulative incidence of any stroke was 1.57 per 100 person‐years (95% CI, 1.45–1.70), with a 1‐year and 5‐year any stroke estimate of 1.70% (95% CI, 1.57–1.84%) and 5.70% (95% CI, 5.37–6.05%), respectively. The cumulative incidence of ischemic stroke was 1.36 per 100 person‐years (95% CI, 1.25–1.48), with a 1‐year and 5‐year ischemic stroke estimate of 1.42% (95% CI, 1.30–1.54%) and 5.03% (95% CI, 4.71–5.36%), respectively. The cumulative incidence of death was 10.82 per 100 person‐years (95% CI, 10.49–11.13), with a 5‐year mortality estimate of 44.34% (95% CI, 43.35–45.23%). Conclusions Long‐term stroke rates in a large nationally representative cohort of Medicare patients following LAAO were low and durably consistent during long‐term follow‐up despite a high thromboembolic risk. High mortality rates in this elderly population underscore the importance of incorporating patient values and preferences when considering LAAO.
Clinical Presentation and Surgical Outcomes of Intestinal Malrotation with Congenital Peritoneal Encapsulation (Cocoon Deformity)
Mirande, Maxwell D. , Baxter, Jacob , Mirande, Mitchell H. , Gomaa, Ibrahim A. , Dozois, Eric J. , Perry, William

World Journal of Colorectal Surgery | August 6, 2025 | Volume: 14 | Issue: 3 | Pages: 103-107

10.4103/wjcs.wjcs_17_25 Get It

Abstract Background: Congenital peritoneal encapsulation (cocoon deformity) is a rare variant of intestinal malrotation. Objectives: To characterize the clinical presentation and outcomes in patients undergoing surgery for intestinal malrotation with cocoon deformity. Design: Retrospective review. Settings: A large tertiary care center, from January 2003 to December 2022. Patients and Methods: All patients who underwent surgery for intestinal malrotation with cocoon deformity were included. Sample Size: Nine patients were identified. Main Outcome Measures: Patient demographics and operative outcomes. Results: Most patients were female (88.9%), with a median age of 37 years (interquartile range [IQR], 19–53). Most were symptomatic upon diagnosis (88.9%), with abdominal pain (77.8%) being the most common symptom. One patient presented acutely, requiring immediate surgical intervention. Computed tomography was the most frequently used modality to establish a diagnosis of intestinal malrotation. A laparoscopic Ladd procedure was attempted in all patients, with three requiring conversion to open surgery. The median operative time was 119 min (IQR, 96.5–202), with a median estimated blood loss of 25 mL (IQR, 15–125). The median length of hospital stay was 2 days (IQR, 1.5–7). The most common postoperative complications were ileus ( n = 3, 33.3%) and 30-day readmission ( n = 3, 33.3%). Most patients experienced partial or complete resolution of symptoms ( n = 7, 77.8%) and no patients required reoperation. The median follow-up duration was 71.8 months (IQR, 21.3–138.7). Conclusions: The laparoscopic Ladd procedure with excision of the cocoon deformity can be performed safely and is associated with significant improvement in preoperative symptoms. Limitations: Cocoon deformity was not diagnosed preoperatively, and there is currently no gold standard imaging modality for its detection.
Dynamic Fluid‐Assisted Continuous Multimaterial 3D Printing for Seamless Gradient Structures (Adv. Mater. Technol. 15/2025)
Wang, Wenbo , Liu, Siying , Liu, Luyang , Nogueira, Cauê , Ma, Xiaoli , Xu, Xin , Shefi, Orit , Lancaster, Jessica N. , Chen, Xiangfan

Advanced Materials Technologies | August 6, 2025 | Volume: 10 | Issue: 15 | Pages: No page available

10.1002/admt.70217 Get It